Performance data is updated to 28 February 2026.
S&P Biotech ETF
The Global X S&P Biotech ETF (CURE) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology.
Investment Focus
Exposure Regions
Portfolio Breakdown
Top 10 Holdings (16.49% of total assets)
| Symbol | Company Name | % assets |
|---|---|---|
| MODERNA INC | 2.27% | |
| ROIVANT SCIENCES | 1.79% | |
| ARCELLX INC | 1.72% | |
| VAXCYTE INC | 1.71% | |
| REVOLUTION MEDIC | 1.59% | |
| AMICUS THERAPEUT | 1.53% | |
| PRAXIS PRECISION | 1.49% | |
| GILEAD SCIENCES | 1.49% | |
| AMGEN INC | 1.47% | |
| BIOMARIN PHARMAC | 1.43% |
| Sector | % assets |
|---|---|
| Health Care | 100.02% |
Similar ETFs
Disclaimer
The information provided on ReviewETF.com.au is intended for general information and comparison purposes only. It is compiled and presented on a best-endeavours basis from publicly available sources, but we do not guarantee its accuracy, completeness, timeliness, or suitability for any particular purpose.
No content on this website constitutes financial advice, investment recommendation, solicitation, or an offer to buy or sell any securities. Past performance is not indicative of future results, and all investments carry risk, including the potential loss of capital.
The point of truth for any ETF is always the official product disclosure statement (PDS), website, and announcements from the ETF issuer/provider (e.g., Vanguard, BetaShares, iShares, VanEck, etc.). We link directly to these primary sources on each individual ETF page wherever possible—please verify all details there before making any decisions.
ReviewETF.com.au, its owner (Joshua), and any associated entities disclaim all liability for any loss or damage arising from the use of, or reliance on, information contained on this site. Users should seek independent professional financial advice tailored to their personal circumstances.
This website may contain links to third-party sites; we are not responsible for their content or privacy practices.
Last updated: January 2026
